Haemodialysis and peritoneal dialysis market, valued at USD 104.08 billion in 2023, is projected to grow at a compound annual growth rate (CAGR) of 9.3%, reaching nearly USD 193.96 billion by 2030. This growth is fueled by the increasing prevalence of end-stage renal disease (ESRD), technological innovations, and a shift towards home-based dialysis therapies.
Request Free Sample Report:
https://www.maximizemarketresearch.com/request-sample/228429/
Market Overview
Haemodialysis currently dominates the market due to its established infrastructure. However, peritoneal dialysis is gaining traction owing to its portability and suitability for home-based treatments. The rising incidence of ESRD, attributed to factors such as aging populations, diabetes, and hypertension, necessitates a growing number of dialysis services.
Key Market Drivers
Increasing ESRD Prevalence: Chronic kidney disease (CKD) is on the rise globally, with prevalence approaching 10% in many regions. This surge is primarily due to lifestyle-related conditions like diabetes and hypertension, leading to a higher demand for dialysis treatments.
Technological Advancements: Innovations such as wearable artificial kidneys, biocompatible dialysis solutions, telehealth integration, and AI-powered systems are enhancing patient outcomes and expanding treatment options. These advancements are attracting investments and establishing new markets.
Shift Towards Home-Based Therapies: Patient preferences for improved quality of life and potential cost savings are driving the adoption of home-based dialysis therapies, particularly peritoneal dialysis. This trend is creating opportunities for companies offering home dialysis equipment and remote monitoring systems.
Market Segmentation
By Modality:
Haemodialysis: Expected to maintain dominance, though its market share may decline to 60% by 2030 due to the rise of home-based therapies.
Peritoneal Dialysis: Anticipated to grow to 40% market share by 2030, driven by increased adoption of home-based treatments.
Regional Insights
Developed Regions: North America and Europe are projected to continue dominating the market, supported by advanced healthcare infrastructure and higher adoption rates of innovative dialysis solutions.
Emerging Markets: Asia and South America are expected to experience faster growth due to rising ESRD prevalence and improvements in healthcare infrastructure, presenting opportunities for affordable and accessible treatment solutions.
Key Players
Leading companies in the haemodialysis and peritoneal dialysis market include:
Fresenius Medical Care
Baxter International
These organizations are investing in home dialysis growth, wearable technology, and AI for personalized care, aiming to enhance patient outcomes and expand their market presence.
Conclusion
The global haemodialysis and peritoneal dialysis market is poised for significant growth, driven by the increasing prevalence of ESRD, technological advancements, and a shift towards home-based therapies. Stakeholders are encouraged to invest in innovative solutions and infrastructure to meet the evolving needs of patients worldwide.
Related Report:
https://www.maximizemarketresearch.com/market-report/mechanical-electrical-and-plumbing-software-market/190814/
https://www.maximizemarketresearch.com/market-report/text-to-video-ai-market/190642/
About Us
Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries such as IT & telecom, chemical, food & beverage, aerospace & defense, healthcare and others.
MAXIMIZE MARKET RESEARCH PVT. LTD.
2nd Floor, Navale IT park Phase 3,
Pune Banglore Highway, Narhe
Pune, Maharashtra 411041, India.
+91 9607365656
sales@maximizemarketresearch.com
Locked
